| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 08/20/2008 | EP1956978A1 Phantom for diffusion tensor imaging |
| 08/20/2008 | EP1743174A4 Multimodality nanostructures, methods of fabrication thereof, and methods of use thereof |
| 08/20/2008 | EP1140209B1 Blood pool agents for nuclear magnetic resonance diagnostics |
| 08/20/2008 | EP1047455B1 Para-hydrogen labelled agents and their use in non-proton magnetic resonance imaging |
| 08/20/2008 | EP0724651B1 Synthetic human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 08/20/2008 | CN101245002A Process for producing steady iodination vegetable oil, iodination vegetable oil fatty acid ethyl ester |
| 08/20/2008 | CN101244280A Interfere function of panaxoside Rg1 for self immunity myeloencephalitis mouse |
| 08/20/2008 | CN101244279A Method for sifting medicament from microorganism metabolite by using mouse model |
| 08/20/2008 | CN101244028A System for positioning delivery of medicament and quantitatively controlling and releasing |
| 08/19/2008 | US7415302 Method and system for leading macromolecule substances into living target cells |
| 08/19/2008 | US7414169 Detecting modulator of preferential gene expression; obtain cell from human or nematode, incubate cells with modulator, monitor cells for decrease in preferential gene expresssion |
| 08/19/2008 | US7414047 Piperazinyl and diazapanyl benzamides and benzthioamides |
| 08/19/2008 | US7413850 Uses of carbamoyl phosphate synthetase for the diagnois of inflammatory diseases and sepsis |
| 08/19/2008 | US7413736 Administering anti-idiotype antibody or antibody fragment comprising heavy chain variable region sequences and light chain variable region sequences conjugated to a soluble immunogenic carrier protein |
| 08/19/2008 | US7413729 Sialic acid permease system |
| 08/19/2008 | US7413728 Immune modulator |
| 08/19/2008 | US7413727 Contrast agents |
| 08/19/2008 | US7413536 Substrates and screening methods for transport proteins |
| 08/14/2008 | WO2008098216A2 Compositions and methods to prevent cancer with cupredoxins |
| 08/14/2008 | WO2008096905A1 Anti-brak (cxcl14) human monoclonal antibody and use thereof |
| 08/14/2008 | WO2008096760A1 NOVEL HEXATRIENE-β-CARBONYL COMPOUND |
| 08/14/2008 | WO2008096280A1 Visualization of biological material by the use of coated contrast agents |
| 08/14/2008 | WO2008096279A1 Compositions containing metal oxide particles and their uses |
| 08/14/2008 | WO2008095603A2 Color-marked oligosaccharides or polysaccharides |
| 08/14/2008 | WO2008095450A2 Negative contrast agent for mri comprising a water suspension of clay and iron oxide nanoparticles |
| 08/14/2008 | WO2008095296A1 Class ii histone deacetylase whole cell enzyme assay |
| 08/14/2008 | WO2007137236A3 Drug loaded contrast agents: combining diagnosis and therapy |
| 08/14/2008 | US20080193762 Water soluble metal and semiconductor nanoparticle complexes |
| 08/14/2008 | US20080193490 Use of Carbon Nanotube for Drug Delivery |
| 08/14/2008 | US20080193482 Method of cancer screening; method of cancer treatment; and method of auto-immune disease treatment |
| 08/14/2008 | US20080193435 Using tryptophanyl-tRNA synthetase as therapeutic in promoting repair of damage associated ischemic events associated with vision |
| 08/14/2008 | US20080193384 having chemical exchange saturation transfer (CEST)-active paramagnetic complexes linked to carriers selected from liposomes, particles, micelles and polypropylenimine dendrimers, used for mapping local pH, temperature, oxygen concentration or metabolites, detection of cancer lesions and inflammation |
| 08/14/2008 | US20080193383 administering delta receptor angonists such as diarylmethyl piperazine and diarylmethyl piperidine compounds; side effect reduction of anesthetics, barbiturates and analgesics |
| 08/14/2008 | US20080193381 Heterodimers of glutamic acid |
| 08/14/2008 | US20080193376 Methods of Enhanced Detection and Therapy of Inflamed Tissues Using Immune Modulation |
| 08/14/2008 | US20080193373 Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders |
| 08/14/2008 | US20080193372 Efficacy and Safety of Targeted Particulate Agents with Decoy Systems |
| 08/14/2008 | DE102007007738A1 Farbmarkierte Oligo- oder Polysaccharide Color-coded oligo- or polysaccharides |
| 08/14/2008 | DE102007005817A1 Biologisch wirksame Vorrichtung und Verfahren zu ihrer Herstellung Biologically effective apparatus and process for their preparation |
| 08/14/2008 | CA2678194A1 Anti-human brak (cxcl14) monoclonal antibody and use thereof |
| 08/14/2008 | CA2675631A1 Visualization of biological material by the use of coated contrast agents |
| 08/13/2008 | EP1955716A2 Radiopaque polymeric stents |
| 08/13/2008 | EP1954321A2 Method of dynamic nuclear polarisation (dnp) using a trityl radical and a paramagnetic metal ion |
| 08/13/2008 | EP1954312A2 Detection of soluble adiponectin receptor peptides and use in diagnostics and therapeutics |
| 08/13/2008 | EP1537867B1 Method of photodynamic diagnosis for vascular diseases |
| 08/13/2008 | EP1251835B1 Closure of bacterial ghosts |
| 08/13/2008 | CN101241788A Biological compatibility magnetic nano crystal for high dissolving and stable distribution in physiologicalbuffer liquid and its making method |
| 08/13/2008 | CN101240020A Breast cancer biological molecule marker LASS2 protein, modifying product and medical composition thereof |
| 08/13/2008 | CN101239928A Propanoic derivatives for treating lipid metabolism disorder |
| 08/12/2008 | US7412279 Systems and methods for targeted magnetic resonance imaging of the vascular system |
| 08/12/2008 | US7411041 DCRS5 polypeptides |
| 08/12/2008 | US7410943 Peptide-based compounds for use as targeting vectors that bind to receptors associated with angiogenesis; may thus be used for diagnosis or therapy of, for example, malignant diseases, heart diseases, endometriosis, inflammation-related diseases, rheumatoid arthritis and Kaposi's s sarcoma |
| 08/12/2008 | US7410756 Methods of modulating angiogenesis |
| 08/12/2008 | US7410633 Determining the degradation rate of a protein or peptide in an individual by administering 2H or 18O labeled water to incorporate the label in the protein and detecting (mass spectrometry) incorporation of the label in a bodily tissue or fluid; collagen, hormones, apolipoproteins, albumin, cloning factor |
| 08/12/2008 | CA2252399C Composition for demonstrating the presence of ammonia in exhaled air |
| 08/07/2008 | WO2008095050A1 Methods for determining cancer resistance to histone deacetylase inhibitors |
| 08/07/2008 | WO2008094834A2 Multi-functional drug carriers |
| 08/07/2008 | WO2008093999A1 Mri t1 contrasting agent comprising manganese oxide nanoparticle |
| 08/07/2008 | WO2008093528A1 Vital staining agent for cancer |
| 08/07/2008 | WO2008093005A2 Preparation for detection of a salivary malfunction |
| 08/07/2008 | WO2008074804A3 Magnetic nanoparticles for the application in hyperthermia, preparation thereof and use in constructs having a pharmacological application |
| 08/07/2008 | US20080188422 Peptides having separate domains; AIDS, cardiovascular disease, hepatitis. diabetes, cancer; side effect reduction |
| 08/07/2008 | US20080187494 Inducing/ enhancing the induction of differentiation of stem cells into embryonic germ layer by culturing the stem cells in the presence of a defined medium free of xeno- and serum-components, of defined factors that contribute to the promotion of differentiation to embryonic germ layer derivatives |
| 08/07/2008 | US20080187493 Peptide-Based Compounds |
| 08/07/2008 | US20080187492 Determining whether a compound, an inhibitor of a glutamate receptor, reduces Fragile X syndrome, a tauopathy, Huntington's disease, neurofibromatosis 1, Parkinson's disease of an analogous disease in a Drosophila |
| 08/07/2008 | US20080187491 Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides |
| 08/07/2008 | US20080187490 Administering a purified polypeptide, with high affinity to the CH2-CH3 domain of an immunoglobulin molecule; inhibiting the binding of immune complexes to effector molecules |
| 08/07/2008 | US20080187488 Phage antibodies to radiation-inducible neoantigens |
| 08/07/2008 | US20080187487 Methods for producing multilayered particles, fibers and sprays and methods for administering the same |
| 08/07/2008 | CA2677118A1 Methods and materials for identifying the origin of a carcinoma of unknown primary origin |
| 08/07/2008 | CA2677000A1 Methods for determining cancer resistance to histone deacetylase inhibitors |
| 08/07/2008 | CA2676912A1 Multi-functional drug carriers |
| 08/07/2008 | CA2655344A1 Models for vaccine assessment |
| 08/06/2008 | EP1951321A2 Nanoparticle-based imaging agents for x-ray/computed tomography |
| 08/06/2008 | EP1951320A2 Methods of analysing cell behaviour |
| 08/06/2008 | EP1744789B1 X-ray and/or uv activatable particles, their preparation and their therapeutic or diagnostic uses |
| 08/06/2008 | EP1585546B1 Kim-1 antagonists and use to modulate immune system |
| 08/06/2008 | EP1449920B1 Trangenic mice used as model for human pathologies originating from stem cells |
| 08/06/2008 | EP1409024B1 Macrocyclic metal complexes and use thereof for production of conjugates with biomolecules |
| 08/06/2008 | EP1173757B1 Diagnosis of human kidney diseases |
| 08/06/2008 | CN101237883A Photosensitizers and MRI enhancers |
| 08/06/2008 | CN101237857A Compositions and methods using microspheres and non-ionic contrast agents |
| 08/06/2008 | CN101235088A Preparation of anti-human seminoprotein specificity single chain antibody and application method thereof |
| 08/05/2008 | US7408095 Methods for introducing heterologous cells into fish to determine if the heterologous cells contain cancer cells or a pathogen |
| 08/05/2008 | US7407939 Protein kinase inhibitors comprising ATP mimetics conjugated to peptides or peptidomimetics |
| 08/05/2008 | US7407934 Controlling blood glucose concentration; amylin antagonist such as 25,28,29Pro-h-amylin, pramlintide; reducing gastric motility and delaying gastric emptying |
| 08/05/2008 | US7407647 with at least one (non)biodegradable polymer; radio-opaque polymeric material provides enhanced contrasting intensity in radiographic imaging; tri(2,3,5-triiodo-phenyl-amidoethyl)-amine and tetra(2,3,5-triido-pheny-ester-methyl)-methane |
| 08/05/2008 | US7407645 Contast agents;magn |
| 08/05/2008 | CA2217494C Novel compositions of lipids and stabilizing materials |
| 07/31/2008 | WO2008092059A2 Tantalum oxide nanoparticles as imaging agents for x-ray/ computed tomography and methods for making same |
| 07/31/2008 | WO2008090500A2 Method for influencing and/or detecting magnetic particles in a region of action, magnetic particles and the use of magnetic particles |
| 07/31/2008 | WO2008089738A2 Ferrous oxide-binding peptides |
| 07/31/2008 | WO2008054509A3 Methods for assessing cell labeling |
| 07/31/2008 | WO2008035985A3 T1 mri trackable drug delivery particles, uses and methods thereof |
| 07/31/2008 | WO2008033031A3 Mri trackable drug delivery particles, uses and methods thereof |
| 07/31/2008 | WO2008005942A3 Activatable probes and methods of use |
| 07/31/2008 | WO2007136892A3 Engineered antibody-stress protein fusions |
| 07/31/2008 | WO2007127813A3 Modulation of signal transduction by site specific ultrasound agent delivery of transmembrane acting compounds |
| 07/31/2008 | US20080181853 nanostructure capsules comprising shells enclosing gas filled hollow cores, rupturable upon exposure to ultrasonic frequencies, to release the gases; consisting an inner layer of polymers and an outer layer of cross-linked amphiphilic materials; echographic imaging of the reticuloendothelial system |
| 07/31/2008 | US20080181852 water soluble polyglutamnylglutamine conjugated to drugs, polydentate ligands, targeting, optical imaging, magnetic resonance imaging or stabilizing agents, having improved bioavailability |